Infinity Pharmaceuticals
Rich Demarco is a seasoned IT Business Systems Analyst with extensive experience in overseeing a diverse range of business systems and project management. Currently serving as a Senior IT Business Systems Analyst at Infinity Pharmaceuticals since June 2008, Rich manages systems such as Oracle Fusion, Oracle E-Business Suite, and Hyperion Planning, among others. Prior experience includes a role as a Business Systems Analyst at Aviva Life Insurance, where Rich leveraged Oracle Discoverer and Cognos reporting tools, and at Keyport Life Insurance Co, handling application changes and enhancements in Treasury Operations. Rich holds a Bachelor of Arts in Communication/Journalism from Boston College, earned from 1986 to 1990.
This person is not in any teams
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.